Furthermore, additional evidence on the effect of low DPP4 levels on an overall reduced immune effector response is supported by the multiple DPP4 inhibitors approved for therapeutic use in different autoimmune diseases [36]. This evidence concerns the gene DPP4 and autoimmune disease.